20.06.2014 • NewsDede WillamsRecipharmCTC

Recipharm and CTC in Clinical Trial Collaboration

CTC Clinical Trial Consultants of Uppsala, Sweden, and compatriot Recipharm Pharmaceutical Development of Solna, Stockholm, Sweden, have begun a collaboration to offer a complete set of packages for Phase I studies including development and manufacture of clinical trial material.

The scope of the cooperation will extend to planning, performing and evaluation of the clinical trial.

Maria Lundberg, general manager Recipharm Pharmaceutical Development, said the link-up will allow the two companies to offer customers faster and more cost-efficient phase I studies. "We can from now on take full responsibility for coordination of the work which might be valuable to small virtual companies."

CTC has "excellent experience" in clinical trials and a unique phase I unit at Uppsala University Hospital (Akademiska Sjukhuset), Lundberg noted.

Beyond shortening project timelines, Bengt Dahlström, CEO of CTC Clinical Trial said the systematic integrated approach will help the companies to obtain more information on the desirable properties of the drug formulation.

"Adaptive design," he said, "is a key element in getting more information from each study and modifying the design based on the data obtained all within a single protocol."

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.